| Income Statement |
| Total Revenue | 164.37M |
|
| Revenues (USD) | 164.37M |
| Cost of Revenue | 60.41M |
| Gross Profit | 103.96M |
| Operating Expenses | 96.24M |
| Research and Development Expense | 25.17M |
| Selling, General and Administrative Expense | 71.07M |
| Operating Income | 7.72M |
| Interest Expense | 4.56M |
| Income Tax Expense | -681.00K |
| Net Income | 4.41M |
| Net Income Common Stock | 4.41M |
| Net Income Common Stock (USD) | 4.41M |
| Consolidated Income | 4.41M |
| Earnings per Basic Share | 0.03 |
| Earnings per Basic Share (USD) | 0.03 |
| Earnings per Diluted Share | 0.03 |
| Earning Before Interest & Taxes (EBIT) | 8.29M |
| Earning Before Interest & Taxes (USD) | 8.29M |
| Weighted Average Shares | 143.54M |
| Weighted Average Shares Diluted | 148.08M |
| Balance Sheet |
| Cash and Equivalents | 184.65M |
| Cash and Equivalents (USD) | 184.65M |
| Trade and Non-Trade Receivables | 1.43B |
| Current Assets | 1.65B |
| Property, Plant & Equipment Net | 190.52M |
| Total Assets | 2.95B |
| Debt Current | 25.37M |
| Total Debt | 429.67M |
| Current Liabilities | 1.62B |
| Debt Non-Current | 404.30M |
| Total Liabilities | 2.03B |
| Accumulated Retained Earnings (Deficit) | -512.15M |
| Accumulated Other Comprehensive Income | -1.48M |
| Shareholders Equity | 917.91M |
| Shareholders Equity (USD) | 917.91M |
| Assets Non-Current | 1.30B |
| Total Debt (USD) | 429.67M |
| Goodwill and Intangible Assets | 1.02B |
| Liabilities Non-Current | 407.69M |
| Trade and Non-Trade Payables | 1.59B |
| Cash Flow |
| Depreciation, Amortization & Accretion | 14.89M |
| Net Cash Flow from Financing | -235.08M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -368.71M |
| Capital Expenditure | -13.12M |
| Issuance (Purchase) of Equity Shares | -14.46M |
| Issuance (Repayment) of Debt Securities | -205.97M |
| Net Cash Flow from Investing | -13.12M |
| Net Cash Flow from Operations | -120.77M |
| Effect of Exchange Rate Changes on Cash | 249.00K |
| Share Based Compensation | 19.68M |